2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination

• DOI: 10.1523/jneurosci.2900-16.2017
• Publication Date: 2017-07-28T01:00:39Z
• Authors: Ana Feliú; Itziar Bonilla de...; Francisco Javier ...; Gloria Hernández-...; Leyre Mestre; Nagore Puente; Silvia Ortega-Gut...; Maria L. López-Ro...; Pedro Grandes; Miriam Mecha; Carmen Guaza
• Keywords: Multiple Sclerosis; 2-AG; Neurogenesis; oligodendrocytes; Down-Regulation; chondroitin sulfate proteoglycans; Arachidonic Acids; TMEV-IDD; Nerve Fibers, Myelinated; neuroinflammation; Glycerides; Mice; 03 medical and health sciences; Neuroinflammation; Animals; Cannabinoid Receptor Agonists; 0303 health sciences; Dose-Response Relationship, Drug; Oligodendrocytes; 3. Good health; Chondroitin sulfate proteoglycans; remyelination; Remyelination; Female; Proteoglycans; Endocannabinoids

The failure to undergo remyelination is a critical impediment to recovery in multiple sclerosis. Chondroitin sulfate proteoglycans (CSPGs) accumulate at demyelinating lesions creating a nonpermissive environment that impairs axon regeneration and remyelination. Here, we reveal a new role for 2-arachidonoylglycerol (2-AG), the major CNS endocannabinoid, in the modulation of CSPGs deposition in a progressive model of multiple sclerosis, the Theiler's murine encephalomyelitis virus-induced demyelinating disease. Treatment with a potent reversible inhibitor of the enzyme monoacylglycerol lipase, which accounts for 85% of the 2-AG degradation in the mouse CNS, modulates neuroinflammation and reduces CSPGs accumulation and astrogliosis around demyelinated lesions in the spinal cord of Theiler's murine encephalomyelitis virus-infected mice. Inhibition of 2-AG hydrolysis augments the number of mature oligodendrocytes and increases MBP, leading to remyelination and functional recovery of mice. Our findings establish a mechanism for 2-AG promotion of remyelination with implications in axonal repair in CNS demyelinating pathologies.SIGNIFICANCE STATEMENT The deposition of chondroitin sulfate proteoglycans contributes to the failure in remyelination associated with multiple sclerosis. Here we unveil a new role for 2-arachidonoylglycerol, the major CNS endocannabinoid, in the modulation of chondroitin sulfate proteoglycan accumulation in Theiler's murine encephalomyelitis virus-induced demyelinating disease. The treatment during the chronic phase with a potent reversible inhibitor of the enzyme monoacylglycerol lipase, which accounts for 85% of the 2-arachidonoylglycerol degradation in the mouse CNS, modulates neuroinflammation and reduces chondroitin sulfate proteoglycan deposition around demyelinated lesions in the spinal cord of Theiler's murine encephalomyelitis virus-infected mice. The increased 2-arachidonoylglycerol tone promotes remyelination in a model of progressive multiple sclerosis ameliorating motor dysfunction.